Trump signed an EO to reschedule cannabis, lifting 280E taxes for US MSOs like Cresco Labs, as shares fell on profit taking.

Trump told reporters Monday that he was considering signing an executive order that would make cannabis a Schedule III drug, changing its long-held Schedule I status.

Tilray's stock recently underwent a 1:10 reverse split, and President Trump signed an EO to reschedule cannabis to Schedule ...

"Scromiting" is a symptom of cannabinoid hyperemesis syndrome, a side effect of prolonged marijuana use that results in nausea and vomiting.

An experimental study of heavy drinkers found that smoking cannabis with 7.2% THC reduced their alcohol urge immediately ...

Trump signed an executive order reclassifying marijuana as a less dangerous drug. The change could help the industry without ...

PM on a Friday. The laptop is finally closed. The notifications are silenced. For years, the script has been exactly the same ...

Action News Jax is hearing from a Jacksonville attorney specializing in marijuana law to break down the possible impacts, in ...

"The only way to know is to look at lab tests AND make sure the tests are real. But like buying good clothes, you can get an ...

Detailed price information for Mtl Cannabis Corp. (MTLC-CN) from The Globe and Mail including charting and trades.

Tilray’s stock, and shares of other cannabis companies, soared after reports provided investors hope that President Trump ...

The Sonoma County Board of Supervisors voted 4-1 to adopt revisions to its commercial cannabis ordinance, marking the first ...